TITLE

Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression

AUTHOR(S)
DeBattista, Charles; Hawkins, Jessica
PUB. DATE
May 2009
SOURCE
CNS Drugs;2009, Vol. 23 Issue 5, p369
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Many patients fail to achieve an adequate response to antidepressant medication. Growing evidence suggests that atypical antipsychotics may augment antidepressant effects, resulting in a greater potential for response. Atypical antipsychotics possess pharmacological actions that are associated with antidepressant properties, including serotonin 5-HT2 receptor antagonist and 5-HT1A and dopamine receptor partial agonist activity. In fact, the term `atypical antipsychotic' is an unfortunate remnant of the early indication of these drugs in the treatment of schizophrenia. Soon after their introduction, the usefulness of atypical antipsychotics in bipolar disorder was firmly established and their use in the treatment of mood disorders has far outpaced their use in schizophrenia and other psychotic disorders. Aripiprazole has become the first agent to receive US FDA approval for the adjunctive treatment of unipolar depression. Most recently, Symbyax, a fluoxetine/olanzapine combination, received FDA approval for the acute treatment of treatment-resistant depression. This is the first medication to be FDA approved for this indication. In the present article, the usefulness of antipsychotics in the treatment of resistant unipolar depression is reviewed.
ACCESSION #
43531478

 

Related Articles

  • Acute Bipolar Depression: A Review of the Use of Olanzapine/Fluoxetine. Bobo, William V.; Jr., Richard A. Epstein.; Shelton, Richard C. // Clinical Medicine Insights: Therapeutics;2010, Issue 2, p825 

    Depression is the predominant mood state in patients with bipolar I or II disorder over the course of illness. In spite of this, relatively few pharmacological treatments have been shown to be effective for treating depressive episodes associated with bipolar disorder in adults. Combination...

  • Olanzapine.  // Reactions Weekly;10/30/2004, Issue 1025, p12 

    Presents cases of one woman and four men who developed manic symptoms during treatment with olanzapine for schizophrenia. Dosages received by the patients; Symptoms presented.

  • Chronic depression: Now, a treatable condition. D'Epiro, Nancy Walsh // Patient Care for the Nurse Practitioner;Jan2000, Vol. 3 Issue 1, p54 

    Provides information on chronic depression, a type of mood disorder. Background information on studies regarding chronic depression; Subtypes of chronic depression; Use of antidepressants for the treatment of chronic depression; Clinical implications; Characteristics of psychotherapy. INSET:...

  • Cochrane Briefs. GUIRGUIS-BLAKE, JANELLE // American Family Physician;6/1/2010, Vol. 81 Issue 11, p1335 

    The article discusses a study on the effectiveness and tolerability of aripiprazole compared with other second-generation antipsychotics for schizophrenia. It states that the discontinuation rate in the studies was 38 percent, limiting the validity of the results. The American Psychiatric...

  • The Use of Family History in Selecting Long-Term Treatment for Patients with Bipolar Disorder. Duffy, Anne // Child & Adolescent Psychopharmacology News;Nov2003, Vol. 8 Issue 7, p1 

    The article discusses the advantage of using family history in further diagnosis and treatment of patients with bipolar disorder. It mentions that genetic studies show that mood disorders can be transmitted to other family members. It says that using family history helps determine the treatment...

  • Effective Treatment for Depression: St. John's Wort.  // Annals of the American Psychotherapy Association;Winter2008, Vol. 11 Issue 4, p7 

    The article presents information on a study which examined the therapeutic use of St. John's wort for treating mental depression. Participants of the study were asked to rate the severity of their depression after taking various treatments, using the Hamilton Rating Scale for Depression. The...

  • Investigation of Antidepressant Medication Usage after Bariatric Surgery. Cunningham, Julie; Merrell, Cory; Sarr, Michael; Somers, Kristin; McAlpine, Donald; Reese, Michael; Stevens, Susanna; Clark, Matthew // Obesity Surgery;Apr2012, Vol. 22 Issue 4, p530 

    Background: Many patients seeking bariatric surgery have a history of mood disorders and are actively prescribed antidepressants. While extensive documentation exists on the impact of weight loss surgery on reductions in cardiac, diabetic, and hypertensive medications, little is known about the...

  • Mood Disorders.  // Mood Disorders Fact Sheet;2010, p1 

    The article presents a fact sheet on mood disorders in the U.S. released by the National Institutes of Health (NIH). About 20.9 million American adults suffer from either major depressive disorders, dysthymic disorder and bipolar disorder, which according to NIH research may be treated with...

  • Pharmacologic Treatment of Psychotic Depression. Kripke, Clarissa // American Family Physician;6/1/2006, Vol. 73 Issue 11, p1935 

    The article discusses a study which suggested a treatment for depression with psychotic features. An antidepressant such as imipramine or sertraline was recommended for treating psychotic depression. Details of how the study was conducted are given. Importantly, this article states the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics